18 May 2020
Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis.
Read More
08 May 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
Read More
06 May 2020
Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted.
Read More Auckland-based biotechnology company Pictor has received a double funding boost from government and partners for two crucial development projects to help combat COVID-19 and Mycoplasma bovis. Pictor has received a grant of $500,000 from the $25 million MBIE COVID-19 Innovation Acceleration Fund,
May 18, 2020
New Zealand biotech Avalia Immunotherapies has been awarded bridging funding of $100,000 from the Ministry of Business, Innovation and Employment’s COVID-19 Innovation Acceleration Fund to start work on securing a COVID-19 vaccine for New Zealand, until a national vaccine strategy is in place.
May 8, 2020
Currently, an estimated 2.6 billion people – one-third of the world’s population – are living under some kind of lockdown or quarantine. This is arguably the largest social and economic experiment ever conducted. There are lots of coronavirus memes on the internet, however,&
May 6, 2020
Some of New Zealand’s top scientists are urging the need for a national COVID-19 vaccine programme to ensure New Zealand is best placed to access an effective vaccine at the earliest opportunity. Malaghan Institute Director Professor Graham Le Gros and University of Otago’s Professor Miguel
April 15, 2020
Hi, We’re facing new and fast-moving challenges and opportunities. For most of you this will mean your day to day work will continue, albeit in very different working environments. A significant number of our biotech companies are defined as essential services. If you believe yo
April 2, 2020
“We have made the difficult decision to postpone the MedCan Summit 2020 this week. However, we remain firmly committed to hosting New Zealand’s first medicinal cannabis summit later this year, as the future of large events and international travel becomes clear,” says Dr Zahra Champion, Execu
March 17, 2020
The impact of coronavirus will be far reaching, from increasing reports of the number of infections to the world’s biggest companies painting a bleak picture of broken supply chains, disrupted manufacturing, empty stores and flagging demand for their wares. It is now down to the scientist
March 4, 2020
“New Zealand healthcare professionals who say they don’t know enough about medicinal cannabis now have the best opportunity to change that,” says Dr Zahra Champion, Executive Director of BioTechNZ and MedCan Summit 2020 organiser. With tickets limited, organisers of New Zealand’s first m
March 2, 2020
BiotechNZ is surveying NZ biotechnology companies and supporting organisations to find out the state and future opportunities for biotechnology to contribute to New Zealand’s economic growth. The survey wants to find out where our Kiwi biotech strengths and challenges are, as to enable recomme
February 20, 2020